FY2025 · ended Dec 31, 2025 · Revenue $36.92M, -1.1% YoY · Filed Apr 1, 2026
Lftd Partners Inc. (LIFD) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $36.9 million and a net loss of $24.9 million. Free cash flow was $1.2 million. As of Jun 30, 2026 it held $1.5 million in cash and investments and $855,663 in total debt.
Revenue (TTM)
$35.34M
-3.5% vs year-ago TTM
Net income (TTM)
$-29.88M
-3805.5% vs year-ago TTM
Operating cash flow (TTM)
$1.14M
+201.8% vs year-ago TTM
Free cash flow (TTM)
$963,189
+178.4% vs year-ago TTM
EPS (TTM)
$-2.02
-3805.5% vs year-ago TTM
Dividend per share
None
Shares outstanding
14.82M
+0.0% vs prior year
Net cash
$648,634
as of Jun 30, 2026
Operating margin
-13.4%
FY 2026
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LIFD (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Jacksonville, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1391135
- Former names
- Acquired Sales CORP (until Sep 2, 2021); ACQUIRED SALES CORP (until Sep 2, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $36.9M | $37.3M | $51.6M | $57.4M | $31.7M |
| Operating income | $913,208 | -$773,464 | $2.4M | $9.8M | $7.8M |
| Net income | -$24.9M | -$1.9M | $2.2M | $7.2M | $5.8M |
| Diluted EPS | -$1.68 | -$0.13 | $0.13 | $0.45 | $0.43 |
| Operating cash flow | $1.3M | -$960,067 | $638,925 | $3.0M | $5.6M |
| Free cash flow | $1.2M | -$1.3M | -$150,737 | $2.1M | $5.3M |
| Total assets | $19.3M | $47.6M | $51.3M | $41.1M | $39.4M |
| Total liabilities | $6.6M | $10.1M | $12.5M | $6.6M | $12.0M |
| Stockholders' equity | $12.6M | $37.5M | $38.8M | $34.5M | $27.5M |
| Cash and investments | $1.8M | $2.1M | $4.4M | $3.5M | $1.6M |
| Total debt | $937,988 | $1.2M | $633,060 | $1.9M | $1.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Agreement ended, Acquisition or sale of assets, Regulation FD disclosure
|
Oct 1, 2026 | Sep 29, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 24, 2026 | Jul 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 17, 2026 | Jun 14, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Apr 1, 2026 | Dec 31, 2025 |
All 260 Lftd Partners Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.